Prognostic factor analysis by integrating JALSG clinical trials using TKIs for Ph+ALL with TRUMP data

Prognostic factor analysis by integrating JALSG clinical trials using TKIs for Ph+ALL with TRUMP data - JALSG Ph+ALL TKI-SCT study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041967

Enrollment

246

Registered

2020-10-07

Start date

2020-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Philadelphia chromosome-positive acute lymphoblastic leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have enrolled in the JALSG Ph+ALL202 study, 208 study, or 213 study

Exclusion criteria

Exclusion criteria: Patients rejected the enrollment

Design outcomes

Primary

Measure	Time frame
To identify risk factors for overall survival	—

Secondary

Measure	Time frame
- To identify risk factors for relapse - To identify risk factors for non-relapse mortality - To identify prognostic factors in allogenic hematopoietic cell transplantation - To identify prognostic factors in non-transplant patients - Survival rate, relapse rate, and non-relapse mortality according to identified factors - Indication of allogeneic hematopoietic cell transplantation in the first complete remission	—

Measure

Time frame

- To identify risk factors for relapse - To identify risk factors for non-relapse mortality - To identify prognostic factors in allogenic hematopoietic cell transplantation - To identify prognostic factors in non-transplant patients - Survival rate, relapse rate, and non-relapse mortality according to identified factors - Indication of allogeneic hematopoietic cell transplantation in the first complete remission

—

Countries

Japan

Contacts

Public ContactSatoshi Nishiwaki

Nagoya University Hospital Department of Advanced Medicine

n-3104@med.nagoya-u.ac.jp052-744-2942

Outcome results